Brief: Calithera Biosciences Reports Fourth Quarter 2020 Financial Results And Recent Highlights
March 16 (Reuters) - Calithera Biosciences Inc CALA.O :
* CALITHERA BIOSCIENCES REPORTS FOURTH QUARTER 2020
FINANCIAL
RESULTS AND RECENT HIGHLIGHTS
* CALITHERA BIOSCIENCES INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS TOTALED $115.2 MILLION AT DECEMBER 31, 2020
* CALITHERA BIOSCIENCES - BELIEVES CASH, CASH EQUIVALENTS,
INVESTMENTS AT DEC 31, 2020 WILL BE ENOUGH TO MEET ITS CURRENT
OPERATING PLAN THROUGH 2022
* CALITHERA BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.32
Source text for Eikon: ID:nGNX9lZZTV
Further company coverage: CALA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calithera Biosciences
See all newsBrief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq
Calithera slumps as board approves company liquidation and dissolution
Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution